WallStreetZenWallStreetZen

NASDAQ: CRESY
Cresud Inc Stock

$8.96-0.39 (-4.17%)
Updated Apr 15, 2024
CRESY Price
$8.96
Fair Value Price
N/A
Market Cap
$531.68M
52 Week Low
$5.49
52 Week High
$10.19
P/E
4.3x
P/B
0.89x
P/S
0.63x
PEG
N/A
Dividend Yield
7.51%
Revenue
$544.64M
Earnings
$171.23M
Gross Margin
37.4%
Operating Margin
-2.7%
Profit Margin
23%
Debt to Equity
2.8
Operating Cash Flow
$140M
Beta
1.02
Next Earnings
May 9, 2024
Ex-Dividend
N/A
Next Dividend
N/A

CRESY Overview

Cresud Sociedad Anónima Comercial, Inmobiliaria, Financiera y Agropecuaria, an agricultural company, produces basic agricultural commodities in Brazil and other Latin American countries. It operates through Agricultural Business, and Urban Properties and Investment Business segments. The Agricultural Business segment is involved in the planting, harvesting, and sale of crops, such as wheat, corn, soybeans, cotton, and sunflower, as well as sugarcane; sale of grain derivatives, including flour and oil; breeding, purchasing, and/or fattening of cattle for sale to meat processors and local livestock auction markets; provision of agricultural services; leasing of farms to third parties; disposal and development of farmlands; and brokerage activities. The Urban Properties and Investment Business segment leases, rents, and services commercial and other spaces in shopping malls; leases offices and other rental spaces; develops, maintains, and sells undeveloped parcels of land and/or trading properties; and operates hotels, as well as engages in the entertainment activities. The company was incorporated in 1936 and is headquartered in Buenos Aires, Argentina.

Zen Score

Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CRESY scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CRESY was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CRESY is good value based on its earnings relative to its share price (4.3x), compared to the US market average (41.94x)
P/E vs Market Valuation
CRESY is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CRESY due diligence checks available for Premium users.

Be the first to know about important CRESY news, forecast changes, insider trades & much more!

CRESY News

Valuation

CRESY fair value

Fair Value of CRESY stock based on Discounted Cash Flow (DCF)
Price
$8.96
Fair Value
$4.22
Overvalued by
112.16%
CRESY was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CRESY price to earnings (PE)

For valuing profitable companies with steady earnings
Company
4.3x
Industry
14.74x
Market
41.94x
CRESY is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CRESY is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

CRESY price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.89x
Industry
4.87x
CRESY is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CRESY's financial health

Profit margin

Revenue
$743.2M
Net Income
$171.2M
Profit Margin
23%
CRESY's Earnings (EBIT) of -$14.70M... subscribe to Premium to read more.
Interest Coverage Financials
CRESY's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$4.2B
Liabilities
$2.3B
Debt to equity
2.8
CRESY's short-term assets ($614.81M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CRESY's long-term liabilities ($1.12B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CRESY's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CRESY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$140.4M
Investing
$58.2M
Financing
-$354.2M
CRESY's operating cash flow ($102.90M)... subscribe to Premium to read more.
Debt Coverage Financials

CRESY vs Conglomerate Stocks

TickerMarket Cap1d %P/EP/B
CRESY$531.68M-4.17%4.30x0.89x
TRC$401.27M-1.45%124.83x0.86x
FIP$693.55M-1.87%-3.83x1.43x
SPLP$799.36M+0.21%5.48x0.83x
MATW$817.06M-0.11%24.43x1.61x

Cresud Stock FAQ

What is Cresud's quote symbol?

(NASDAQ: CRESY) Cresud trades on the NASDAQ under the ticker symbol CRESY. Cresud stock quotes can also be displayed as NASDAQ: CRESY.

If you're new to stock investing, here's how to buy Cresud stock.

What is the 52 week high and low for Cresud (NASDAQ: CRESY)?

(NASDAQ: CRESY) Cresud's 52-week high was $10.19, and its 52-week low was $5.49. It is currently -12.11% from its 52-week high and 63.24% from its 52-week low.

How much is Cresud stock worth today?

(NASDAQ: CRESY) Cresud currently has 593,389,883 outstanding shares. With Cresud stock trading at $8.96 per share, the total value of Cresud stock (market capitalization) is $531.68M.

Cresud stock was originally listed at a price of $15.78 in Dec 31, 1997. If you had invested in Cresud stock at $15.78, your return over the last 26 years would have been -43.23%, for an annualized return of -2.15% (not including any dividends or dividend reinvestments).

How much is Cresud's stock price per share?

(NASDAQ: CRESY) Cresud stock price per share is $8.96 today (as of Apr 15, 2024).

What is Cresud's Market Cap?

(NASDAQ: CRESY) Cresud's market cap is $531.68M, as of Apr 16, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cresud's market cap is calculated by multiplying CRESY's current stock price of $8.96 by CRESY's total outstanding shares of 593,389,883.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.